Increased susceptibility to UV-induced skin carcinogenesis in polymerase eta-deficient mice.

Abstract:

:Xeroderma pigmentosum variant (XPV) patients with mutations in the DNA polymerase eta (pol eta) gene are hypersensitive to sunlight and have greatly increased susceptibility to sunlight-induced skin cancer. Consistent with the ability of Pol eta to efficiently bypass UV light-induced cyclobutane pyrimidine dimers, XPV cells lacking Pol eta have diminished capacity to replicate UV-damaged DNA and are sensitive to UV light-induced killing and mutagenesis. To better understand these and other Pol eta functions, we generated Pol eta-deficient mice. Mice homozygous for a null mutation in pol eta are viable, fertile, and do not show any obvious spontaneous defects during the first year of life. However, fibroblasts derived from these mutant mice are sensitive to killing by exposure to UV light, and all Pol eta-deficient mice develop skin tumors after UV irradiation, in contrast to the wild-type littermate controls that did not develop such tumors. These results and biochemical studies of translesion synthesis by mouse Pol eta indicate that Pol eta-dependent bypass of cyclobutane pyrimidine dimers suppresses UV light-induced skin cancer in mice. Moreover, 37.5% of pol eta heterozygous mice also developed skin cancer during 5 months after a 5-month exposure to UV light, suggesting that humans who are heterozygous for mutations in pol eta may also have an increased risk of skin cancer.

journal_name

Cancer Res

journal_title

Cancer research

authors

Lin Q,Clark AB,McCulloch SD,Yuan T,Bronson RT,Kunkel TA,Kucherlapati R

doi

10.1158/0008-5472.CAN-05-1862

subject

Has Abstract

pub_date

2006-01-01 00:00:00

pages

87-94

issue

1

eissn

0008-5472

issn

1538-7445

pii

66/1/87

journal_volume

66

pub_type

杂志文章
  • Haem, not protein or inorganic iron, is responsible for endogenous intestinal N-nitrosation arising from red meat.

    abstract::Many N-nitroso compounds (NOC) are carcinogens. In this controlled study of 21 healthy male volunteers, levels of NOC on a high (420 grams) red meat diet were significantly greater (P = 0.001) than on a low (60 grams) meat diet but not significantly greater when an equivalent amount of vegetable protein was fed. An 8-...

    journal_title:Cancer research

    pub_type: 临床试验,杂志文章,随机对照试验

    doi:

    authors: Cross AJ,Pollock JR,Bingham SA

    更新日期:2003-05-15 00:00:00

  • Properties of immunotoxins against a glycolipid antigen associated with Burkitt's lymphoma.

    abstract::A monoclonal immunoglobulin M (IgM) antibody (38-13) which recognizes Burkitt's lymphoma (BL) cells, by reacting with the neutral glycolipid Gal alpha 1 leads to 4-Gal beta 1 leads to 4-Glc beta 1 leads to 1-ceramide, was recently characterized. This monoclonal IgM was coupled to either ricin A chain or gelonin. The t...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Wiels J,Junqua S,Dujardin P,Le Pecq JB,Tursz T

    更新日期:1984-01-01 00:00:00

  • MAPK kinase 3 is a tumor suppressor with reduced copy number in breast cancer.

    abstract::Cancers are initiated as a result of changes that occur in the genome. Identification of gains and losses in the structure and expression of tumor-suppressor genes and oncogenes lies at the root of the understanding of cancer cell biology. Here, we show that the mitogen-activated protein kinase (MAPK) MKK3 suppresses ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-13-1310

    authors: MacNeil AJ,Jiao SC,McEachern LA,Yang YJ,Dennis A,Yu H,Xu Z,Marshall JS,Lin TJ

    更新日期:2014-01-01 00:00:00

  • The DNA damage response arouses the immune system.

    abstract::Although there is considerable knowledge of how DNA damage triggers cell cycle arrest, DNA repair, and apoptosis, little was known about its potential role in immune responses. Recently, we showed that genotoxic stress and stalled DNA replication forks induce the expression of ligands for the NKG2D receptor found in n...

    journal_title:Cancer research

    pub_type: 杂志文章,评审

    doi:10.1158/0008-5472.CAN-05-4603

    authors: Gasser S,Raulet DH

    更新日期:2006-04-15 00:00:00

  • A tumor-expressed inhibitor of the early but not late complement lytic pathway enhances tumor growth in a rat model of human breast cancer.

    abstract::Membrane-bound complement inhibitors protect host cells from inadvertent complement attack, and complement inhibitors are often up-regulated on tumors, possibly representing a selective adaptation by tumors to escape elimination by a host antitumor immune response. Relevant in vivo studies using rodent models of human...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Caragine TA,Okada N,Frey AB,Tomlinson S

    更新日期:2002-02-15 00:00:00

  • The prolyl isomerase Pin1 is a novel prognostic marker in human prostate cancer.

    abstract::Prostate cancer (PCa) is the most common male cancer in the United States. A major challenge that remains is to predict the clinical outcome in managing PCa patients. The prolyl isomerase Pin1 has been shown to be overexpressed in some human cancer tissues and thought to be an important player in several oncogenic pat...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Ayala G,Wang D,Wulf G,Frolov A,Li R,Sowadski J,Wheeler TM,Lu KP,Bao L

    更新日期:2003-10-01 00:00:00

  • Hyperplastic gastric tumors with spasmolytic polypeptide-expressing metaplasia caused by tumor necrosis factor-alpha-dependent inflammation in cyclooxygenase-2/microsomal prostaglandin E synthase-1 transgenic mice.

    abstract::We showed recently that Helicobacter infection induces expression of cyclooxygenase-2 and microsomal prostaglandin E synthase-1 in the mouse stomach, and that transgenic mice expressing both cyclooxygenase-2 and microsomal prostaglandin E synthase-1 (K19-C2mE mice) develop hyperplastic gastric tumors with inflammatory...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-05-1936

    authors: Oshima M,Oshima H,Matsunaga A,Taketo MM

    更新日期:2005-10-15 00:00:00

  • Undermining Glutaminolysis Bolsters Chemotherapy While NRF2 Promotes Chemoresistance in KRAS-Driven Pancreatic Cancers.

    abstract::Pancreatic cancer is a disease with limited therapeutic options. Resistance to chemotherapies poses a significant clinical challenge for patients with pancreatic cancer and contributes to a high rate of recurrence. Oncogenic KRAS, a critical driver of pancreatic cancer, promotes metabolic reprogramming and upregulates...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-19-1363

    authors: Mukhopadhyay S,Goswami D,Adiseshaiah PP,Burgan W,Yi M,Guerin TM,Kozlov SV,Nissley DV,McCormick F

    更新日期:2020-04-15 00:00:00

  • Mutational Landscape of Pediatric Acute Lymphoblastic Leukemia.

    abstract::Current standard of care for patients with pediatric acute lymphoblastic leukemia (ALL) is mainly effective, with high remission rates after treatment. However, the genetic perturbations that give rise to this disease remain largely undefined, limiting the ability to address resistant tumors or develop less toxic targ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-16-1303

    authors: Ding LW,Sun QY,Tan KT,Chien W,Mayakonda A,Yeoh AEJ,Kawamata N,Nagata Y,Xiao JF,Loh XY,Lin DC,Garg M,Jiang YY,Xu L,Lim SL,Liu LZ,Madan V,Sanada M,Fernández LT,Hema Preethi SS,Lill M,Kantarjian HM,Kornblau SM,

    更新日期:2017-01-15 00:00:00

  • Comparison of different busulfan analogues for depletion of hematopoietic stem cells and promotion of donor-type chimerism in murine bone marrow transplant recipients.

    abstract::Busulfan (1,4-butanediol dimethanesulfonate, BU) is relatively unique among other standard chemotherapy compounds in its ability to deplete noncycling primitive stem cells in the host and consequently to allow for high levels of long-term, donor-type engraftment after bone marrow transplantation (BMT). Such a property...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Westerhof GR,Ploemacher RE,Boudewijn A,Blokland I,Dillingh JH,McGown AT,Hadfield JA,Dawson MJ,Down JD

    更新日期:2000-10-01 00:00:00

  • Eighteenth annual pezcoller symposium: tumor microenvironment and heterotypic interactions.

    abstract::This symposium was held in Trento, Italy, from June 27 to 29, 2006, and was co-chaired by Robert Weinberg and Enrico Mihich. The interactions between tumor cells and their microenvironment were discussed with particular emphasis on their molecular mechanisms. The roles of transforming growth factor beta signaling, uro...

    journal_title:Cancer research

    pub_type:

    doi:10.1158/0008-5472.CAN-06-3149

    authors: Weinberg R,Mihich E

    更新日期:2006-12-15 00:00:00

  • Monoclonal antibodies to glycoproteins of Vinca alkaloid-resistant human leukemic cells.

    abstract::Drug resistance is a major problem in the successful treatment of cancer. Resistance to one drug is often associated with cross-resistance to other anticancer agents. This is commonly seen with the "natural product" anticancer drugs such as the Vinca alkaloids and anthracyclines. In experimental systems, specific chan...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Danks MK,Metzger DW,Ashmun RA,Beck WT

    更新日期:1985-07-01 00:00:00

  • Fumitremorgin C reverses multidrug resistance in cells transfected with the breast cancer resistance protein.

    abstract::Fumitremorgin C (FTC) is a potent and specific chemosensitizing agent in cell lines selected for resistance to mitoxantrone that do not overexpress P-glycoprotein or multidrug resistance protein. The gene encoding a novel transporter, the breast cancer resistance protein (BCRP), was recently found to be overexpressed ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Rabindran SK,Ross DD,Doyle LA,Yang W,Greenberger LM

    更新日期:2000-01-01 00:00:00

  • Altered Cell-Cycle Control, Inflammation, and Adhesion in High-Risk Persistent Bronchial Dysplasia.

    abstract::Persistent bronchial dysplasia is associated with increased risk of developing invasive squamous cell carcinoma (SCC) of the lung. In this study, we hypothesized that differences in gene expression profiles between persistent and regressive bronchial dysplasia would identify cellular processes that underlie progressio...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-17-3822

    authors: Merrick DT,Edwards MG,Franklin WA,Sugita M,Keith RL,Miller YE,Friedman MB,Dwyer-Nield LD,Tennis MA,O'Keefe MC,Donald EJ,Malloy JM,van Bokhoven A,Wilson S,Koch PJ,O'Shea C,Coldren C,Orlicky DJ,Lu X,Baron AE,Hickey

    更新日期:2018-09-01 00:00:00

  • BCL2 suppresses PARP1 function and nonapoptotic cell death.

    abstract::BCL2 suppresses apoptosis by binding the BH3 domain of proapoptotic factors and thereby regulating outer mitochondrial membrane permeabilization. Many tumor types, including B-cell lymphomas and chronic lymphocytic leukemia, are dependent on BCL2 for survival but become resistant to apoptosis after treatment. Here, we...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-11-4204

    authors: Dutta C,Day T,Kopp N,van Bodegom D,Davids MS,Ryan J,Bird L,Kommajosyula N,Weigert O,Yoda A,Fung H,Brown JR,Shapiro GI,Letai A,Weinstock DM

    更新日期:2012-08-15 00:00:00

  • Circulating tumor cell isolation and diagnostics: toward routine clinical use.

    abstract::From February 7-11, 2011, the multidisciplinary Lorentz Workshop Circulating Tumor Cell (CTC) Isolation and Diagnostics: Toward Routine Clinical Use was held in Leiden (The Netherlands) to discuss progress and define challenges and potential solutions for development of clinically useful circulating tumor cell (CTC) d...

    journal_title:Cancer research

    pub_type:

    doi:10.1158/0008-5472.CAN-11-1254

    authors: van de Stolpe A,Pantel K,Sleijfer S,Terstappen LW,den Toonder JM

    更新日期:2011-09-15 00:00:00

  • Targeting the EWSR1-FLI1 oncogene-induced protein kinase PKC-β abolishes ewing sarcoma growth.

    abstract::Ewing sarcoma is a rare but aggressive disease most common in young adults. This cancer is driven by a unique chimeric fusion oncogene but targeted strategies have been elusive. Here we report the identification of the protein kinase PKC-ß (PRKCB) as a disease-specific druggable target for treatment of Ewing sarcoma. ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-12-0371

    authors: Surdez D,Benetkiewicz M,Perrin V,Han ZY,Pierron G,Ballet S,Lamoureux F,Rédini F,Decouvelaere AV,Daudigeos-Dubus E,Geoerger B,de Pinieux G,Delattre O,Tirode F

    更新日期:2012-09-01 00:00:00

  • PML/RARα-Regulated miR-181a/b Cluster Targets the Tumor Suppressor RASSF1A in Acute Promyelocytic Leukemia.

    abstract::In acute promyelocytic leukemia (APL), all-trans retinoic acid (ATRA) treatment induces granulocytic maturation and complete remission of leukemia. microRNAs are known to be critical players in the formation of the leukemic phenotype. In this study, we report downregulation of the miR-181a/b gene cluster in APL blasts...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-14-3521

    authors: Bräuer-Hartmann D,Hartmann JU,Wurm AA,Gerloff D,Katzerke C,Verga Falzacappa MV,Pelicci PG,Müller-Tidow C,Tenen DG,Niederwieser D,Behre G

    更新日期:2015-08-15 00:00:00

  • Deletions on chromosome 16 in primary familial breast carcinomas are associated with development of distant metastases.

    abstract::Genetic alterations that occur in human breast cancers are believed to be of importance for initiation as well as progression of the disease. In order to find a genetic alteration that may be used as a prognostic marker, 82 familial breast carcinomas were analyzed for loss of constitutional heterozygosity at polymorph...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Lindblom A,Rotstein S,Skoog L,Nordenskjöld M,Larsson C

    更新日期:1993-08-15 00:00:00

  • Enhanced radiation sensitivity in HPV-positive head and neck cancer.

    abstract::Patients with human papillomavirus (HPV+)-associated head and neck cancer (HNC) show significantly improved survival outcome compared with those with HPV-negative (HPV-) tumors. Published data examining this difference offers conflicting results to date. We systematically investigated the radiation sensitivity of all ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-13-0587

    authors: Kimple RJ,Smith MA,Blitzer GC,Torres AD,Martin JA,Yang RZ,Peet CR,Lorenz LD,Nickel KP,Klingelhutz AJ,Lambert PF,Harari PM

    更新日期:2013-08-01 00:00:00

  • Direct correlation between nitric oxide synthase II inducibility and metastatic ability of UV-2237 murine fibrosarcoma cells carrying mutant p53.

    abstract::The relationship between nitric oxide synthase II (NOS II) inducibility and the metastatic ability of UV-2237 murine fibrosarcoma cells was determined. Highly metastatic cells survived to produce numerous lung metastases after i.v. injection in syngeneic C3H/HeN mice, whereas poorly metastatic cells did not. Highly me...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Shi Q,Huang S,Jiang W,Kutach LS,Ananthaswamy HN,Xie K

    更新日期:1999-05-01 00:00:00

  • Comparison of virus reactivation, DNA base damage, and cell cycle effects in autologous human melanoma cells resistant to methylating agents.

    abstract::A human melanoma cell line (MM253c1-3D) having an induced stable resistance to the methylating agents 5-(3'-methyl-1-triazeno)imidazole-4-carboxamide, methylnitrosourea, and N-methyl-N'-nitro-N-nitrosoguanidine gave more efficient replication of 5-(3'-methyl-1-triazeno)imidazole-4-carboxamide-treated adenovirus 5 than...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Hayward IP,Parsons PG

    更新日期:1984-01-01 00:00:00

  • Infrequent loss of chromosomal heterozygosity in human stomach cancer.

    abstract::By molecular genetic approach using polymorphic DNA markers which detect allelic deletion at specific chromosomal loci, we analyzed 30 human stomach cancers for possible loss of chromosomal heterozygosity. We analyzed 25 loci on 18 different chromosomes covering regions frequently deleted in several types of cancers. ...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Wada M,Yokota J,Mizoguchi H,Sugimura T,Terada M

    更新日期:1988-06-01 00:00:00

  • Dysfunction of Poly (ADP-Ribose) Glycohydrolase Induces a Synthetic Lethal Effect in Dual Specificity Phosphatase 22-Deficient Lung Cancer Cells.

    abstract::Poly (ADP-ribose) glycohydrolase (PARG) is the main enzyme responsible for catabolism of poly (ADP-ribose) (PAR), synthesized by PARP. PARG dysfunction sensitizes certain cancer cells to alkylating agents and cisplatin by perturbing the DNA damage response. The gene mutations that sensitize cancer cells to PARG dysfun...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-18-1037

    authors: Sasaki Y,Fujimori H,Hozumi M,Onodera T,Nozaki T,Murakami Y,Ashizawa K,Inoue K,Koizumi F,Masutani M

    更新日期:2019-08-01 00:00:00

  • Frequent epigenetic inactivation of RASSF1A by aberrant promoter hypermethylation in human gastric adenocarcinoma.

    abstract::Methylation associated inactivation of RASSF1, a putative tumor suppressor identified at 3p21.3, has been frequently observed in several human malignancies, including lung and breast cancers. To explore the penetrance of RASSF1 in gastric carcinogenesis, we performed expression and mutation analyses of 3 isotypes of R...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Byun DS,Lee MG,Chae KS,Ryu BG,Chi SG

    更新日期:2001-10-01 00:00:00

  • Polo-like kinase 1 (Plk1) as a novel drug target in chronic myeloid leukemia: overriding imatinib resistance with the Plk1 inhibitor BI 2536.

    abstract::In most patients with chronic myeloid leukemia (CML), the disease can be kept under control using the BCR/ABL kinase inhibitor imatinib. Nevertheless, resistance or intolerance to imatinib and other BCR/ABL inhibitors may occur during therapy. Therefore, CML research is focusing on novel targets and targeted drugs. Po...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-09-2181

    authors: Gleixner KV,Ferenc V,Peter B,Gruze A,Meyer RA,Hadzijusufovic E,Cerny-Reiterer S,Mayerhofer M,Pickl WF,Sillaber C,Valent P

    更新日期:2010-02-15 00:00:00

  • Overexpression of laminin gamma2 chain monomer in invading gastric carcinoma cells.

    abstract::Laminin (LN)-5, a heterotrimer of alpha3, beta3, and gamma2 chains, has been suggested to be involved in tumor cell invasion. The present immunohistochemical study investigated the distribution of the LN gamma2 chain in 48 different human gastric adenocarcinomas. The immunohistochemical analysis showed two distinct pa...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Koshikawa N,Moriyama K,Takamura H,Mizushima H,Nagashima Y,Yanoma S,Miyazaki K

    更新日期:1999-11-01 00:00:00

  • Preclinical evaluation of novel glutamate-urea-lysine analogues that target prostate-specific membrane antigen as molecular imaging pharmaceuticals for prostate cancer.

    abstract::Prostate-specific membrane antigen (PSMA) is expressed in normal human prostate epithelium and is highly up-regulated in prostate cancer. We previously reported a series of novel small molecule inhibitors targeting PSMA. Two compounds, MIP-1072, (S)-2-(3-((S)-1-carboxy-5-(4-iodobenzylamino)pentyl)ureido)pentanedioic a...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:10.1158/0008-5472.CAN-09-1682

    authors: Hillier SM,Maresca KP,Femia FJ,Marquis JC,Foss CA,Nguyen N,Zimmerman CN,Barrett JA,Eckelman WC,Pomper MG,Joyal JL,Babich JW

    更新日期:2009-09-01 00:00:00

  • Immunization of colorectal cancer patients with modified ovine submaxillary gland mucin and adjuvants induces IgM and IgG antibodies to sialylated Tn.

    abstract::Tn and sialylated Tn (sTn) are blood group-related epitopes expressed on mucins of colon carcinoma and other epithelial tumors and are, therefore, potential targets for immunological control. We have immunized 20 colorectal cancer patients at high risk for recurrence with a vaccine consisting of partially desialylated...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: O'Boyle KP,Zamore R,Adluri S,Cohen A,Kemeny N,Welt S,Lloyd KO,Oettgen HF,Old LJ,Livingston PO

    更新日期:1992-10-15 00:00:00

  • Inhibition of growth of HT-29 human colon cancer xenografts in nude mice by treatment with bombesin/gastrin releasing peptide antagonist (RC-3095).

    abstract::Nude mice bearing xenografts of HT-29 human colon cancer cell line were treated for 4 weeks with a [D-Trp6] agonist of luteinizing hormone releasing hormone (LH-RH), somatostatin analogue (RC-160), and bombesin/gastrin releasing peptide antagonist (RC-3095). Some inhibitory effect of [D-Trp6] LH-RH microcapsules relea...

    journal_title:Cancer research

    pub_type: 杂志文章

    doi:

    authors: Radulovic S,Miller G,Schally AV

    更新日期:1991-11-01 00:00:00